CLINICAL_TRIALS
trial_result
· 2023-05-09
Clinical Trial Update: Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) [Phase 1]
Summary
Phase 1 clinical trial evaluating defibrotide therapy for COVID-19–related acute respiratory distress syndrome is completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gregory Yanik | Conditions: COVID, Sars-CoV2 | Phase 1 | Status: COMPLETED | Results posted: 2023-05-09